4.8 Article

Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies

期刊

ELIFE
卷 6, 期 -, 页码 -

出版社

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.27389

关键词

-

类别

资金

  1. Comprehensive Antibody-Vactine Immune Monitoring Consortium [1032144]
  2. National Institute of Allergy and Infectious Diseases [HIVRAD P01 AI100148]
  3. Bill and Melinda Gates Foundation [1040753]
  4. National Institutes of Health [GM082545-06, G20-RR31199, S10-RR025067, SIG S10-OD018149]

向作者/读者索取更多资源

The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The prefusion Env trimer is stabilized by V1V2 loops that interact at the trimer apex. Broadly neutralizing antibodies (bNAbs) against V1V2 loops, exemplified by PG9, bind asymmetrically as a single Fab to the apex of the symmetric Env trimer using a protruding CDRH3 to penetrate the Env glycan shield. Here we characterized a distinct mode of V1V2 epitope recognition by the new bNAb BG1 in which two Fabs bind asymmetrically per Env trimer using a compact CDRH3. Comparisons between cryo-EM structures of Env trimer complexed with BG1 (6.2 A resolution) and PG9 (11.5 angstrom resolution) revealed a new V1V2-targeting strategy by BG1. Analyses of the EM structures provided information relevant to vaccine design including molecular details for different modes of asymmetric recognition of Env trimer and a binding model for BG1 recognition of V1V2 involving glycan flexibility.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据